Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 28 05 2018
accepted: 27 11 2018
revised: 22 10 2018
pubmed: 6 12 2018
medline: 21 3 2019
entrez: 6 12 2018
Statut: ppublish

Résumé

Wilms tumors growing in a botryoid fashion into the renal pelvis have been reported since the 1960s as a rare tumor type usually associated with stromal histology and a good prognosis. However, the true frequency, association with Wilms tumor subtypes, and stage have never been comprehensively studied. We analyzed all Wilms tumors enrolled into the International Society of Paediatric Oncology (SIOP) United Kingdom 2001 Trial (2001-2011), which showed botryoid growth. In addition, we reviewed published series reporting papers on botryoid Wilms tumors. 77/739 patients (10.4%) showed at least one Wilms tumor with a botryoid pattern, and they were sub-classified according to the SIOP criteria as follows: 28 stromal, 21 mixed, 7 regressive, 3 completely necrotic, 4 blastemal, 2 epithelial, 3 diffuse anaplasia, 1 focal anaplasia, and 10 non-anaplastic type (treated with primary surgery). Stage was as follows: 25 stage I, 21 stage II, 12 stage III, 11 stage IV, and 8 stage V. In six cases, local pathologists incorrectly upstaged the tumor from stage I to stage II based on botryoid growth. The event-free and overall survivals were 90 and 96%, respectively. We concluded that botryoid growth pattern is a common finding in Wilms tumor and that all histological types and stages can share this feature. The botryoid growth itself is not a criterion for stage II. Botryoid Wilms tumor is not an entity but merely represents a pattern of tumor growth; such tumors should be sub-classified according to their overall histological features, which will determine treatment and prognosis.

Identifiants

pubmed: 30515564
doi: 10.1007/s00428-018-2500-4
pii: 10.1007/s00428-018-2500-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-234

Références

Int J Urol. 1999 Jul;6(7):369-73
pubmed: 10445307
Pediatr Nephrol. 2000 Jan;14(1):59-61
pubmed: 10654334
Med Pediatr Oncol. 2002 Feb;38(2):79-82
pubmed: 11813170
J Pediatr Surg. 2003 Jul;38(7):E4-5
pubmed: 12861590
J Pediatr Surg. 1992 Jan;27(1):133
pubmed: 1313099
Pediatr Surg Int. 2005 Jan;21(1):43-6
pubmed: 15459779
Acta Cytol. 2006 Jan-Feb;50(1):115-8
pubmed: 16514855
Urology. 2006 Apr;67(4):845.e15-7
pubmed: 16600349
J Urol. 1976 Apr;115(4):467-8
pubmed: 177791
Urology. 1976 Sep;8(3):288-9
pubmed: 184574
Hum Pathol. 1976 Nov;7(6):613-23
pubmed: 186382
J Pediatr Surg. 2008 Sep;43(9):1625-9
pubmed: 18778996
J Clin Pathol. 2010 Feb;63(2):102-9
pubmed: 19687012
Urology. 2010 Jul;76(1):149-52
pubmed: 19914700
Arch Pediatr. 2010 Dec;17(12):1664-6
pubmed: 20943355
Acta Pathol Jpn. 1990 Jun;40(6):417-24
pubmed: 2168119
World J Pediatr. 2011 Aug;7(3):274-6
pubmed: 21822996
BMJ Case Rep. 2012 Sep 07;2012:null
pubmed: 22962373
World J Surg Oncol. 2013 May 20;11:102
pubmed: 23687909
Am Soc Clin Oncol Educ Book. 2014;:215-23
pubmed: 24857079
Arch Pathol Lab Med. 2015 Oct;139(10):1281-7
pubmed: 25989287
Turk J Pediatr. 1987 Jan-Mar;29(1):45-9
pubmed: 2829401
Pediatr Blood Cancer. 2017 Nov;64(11):null
pubmed: 28383760
Urology. 2017 Nov;109:175-177
pubmed: 28502598
Radiology. 1987 May;163(2):385-6
pubmed: 3031726
J Urol Nephrol (Paris). 1970 Oct-Nov;76(10):938-49
pubmed: 4323073
J Urol. 1972 Jan;107(1):142-3
pubmed: 4333460
Br J Urol. 1974 Aug;46(4):409-13
pubmed: 4370540
J Urol. 1968 Oct;100(4):424-6
pubmed: 5677377
J Urol. 1980 Jun;123(6):943-4
pubmed: 6247516
J Urol. 1980 Jul;124(1):130-1
pubmed: 6251282
Am J Surg Pathol. 1981 Apr;5(3):297-306
pubmed: 6263119
J Urol. 1983 Sep;130(3):541-3
pubmed: 6310162
Arch Pathol Lab Med. 1984 Feb;108(2):147-8
pubmed: 6320758
J Urol. 1993 Sep;150(3):936-9
pubmed: 8393946
Br J Urol. 1993 Aug;72(2):251-2
pubmed: 8402036
Pediatr Radiol. 1995 Nov;25 Suppl 1:S68-9
pubmed: 8577559
Pediatr Radiol. 1997 Oct;27(10):818-20
pubmed: 9323251
Arch Pathol Lab Med. 1998 Oct;122(10):925-8
pubmed: 9786356

Auteurs

Gordan M Vujanić (GM)

Department of Pathology, Sidra Medicine, H2M Pathology Room 2MF 140, Al Luqta Street, Doha, Qatar. gvujanic@sidra.org.

Marco Schiavo Lena (M)

Department of Pathology, Ospitale San Raffaele, Milan, Italy.

Neil J Sebire (NJ)

Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH